Premedication with Montelukast and Rupatadine Decreased Rituximab Infusion Time, Rate, Severity of Reactions, and Use of Rescue Medications.
Sign Up to like & getrecommendations! Published in 2020 at "International journal of cancer"
DOI: 10.1002/ijc.32985
Abstract: Rituximab-associated infusion reactions (IRs) are significant burdens on oncology patients, caregivers, and healthcare providers. We evaluated whether montelukast and rupatadine improve rituximab delivery, decrease frequency/severity of IRs and the number of medications used to control… read more here.
Keywords: rupatadine; schedule; group; rituximab infusion ... See more keywords
Peripheral Ulcerative Keratitis in a Young Lady with Systemic Lupus Erythematosus Post Rituximab Infusion-A Case Report
Sign Up to like & getrecommendations! Published in 2022 at "Ocular Immunology and Inflammation"
DOI: 10.1080/09273948.2022.2037654
Abstract: ABSTRACT Aim We report a new ocular finding of episcleritis (OD) and peripheral ulcerative keratitis (OS) in a 40-year-old lady with a 13-year history of systemic lupus erythematosus (SLE), 3 weeks post-rituximab infusion. Materials &… read more here.
Keywords: peripheral ulcerative; rituximab infusion; post rituximab;
1135: A CASE OF MYASTHENIC CRISIS PRECIPITATED BY RITUXIMAB INFUSION
Sign Up to like & getrecommendations! Published in 2020 at "Critical Care Medicine"
DOI: 10.1097/01.ccm.0000643476.07567.7e
Abstract: Introduction: Myasthenia Gravis is an autoimmune condition that affects the neuromuscular junction. Acute respiratory failure due to myasthenic weakness is a known complication of Myasthenia Gravis. Rituximab infusion for refractory myasthenia gravis has been well… read more here.
Keywords: myasthenic crisis; myasthenia gravis; rituximab infusion;